Drugs / Proxicam
last change Oct 2023 re-read 3 minutes ago

Proxicam

Developed for
migraine disorder
Investigated by
Kanuni Sultan Suleyman Training and Research Hospital

Trials 1

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT06118190 Jan 2019 → Dec 2020 migraine disorder Kanuni Sultan Suleyman Training and Research Hospital Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Proxicam “The Effectiveness of Mesotherapy (Lidocaine and Proxicam) in the Treatment of Chronic Migraine” NCT06118190 ↗